After almost two years of COVID-19 pandemic, we are still in a condition where we are not able to go everywhere, seeing each other to discuss ideas and projects, mainly managing videocalls, webinars, remote meetings and conferences. Something is moving on, though not as in the past.
However, challenges for pharmaceutical space have not changed at all, even enforced by the pandemic. Vaccines have involved several companies, innovators and manufacturers, the efforts have been and are great, supporting properly the needs. Actually, it is still a work in progress.
Login now to read the full article
Don’t have an account yet? Subscribe now, it’s free!
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt.
All pubblications
archive from 2022 to today
All articles
PDF Version
Receive our latest issue alerts
directly to your mailbox
